2001
DOI: 10.1006/jmbi.2001.4953
|View full text |Cite
|
Sign up to set email alerts
|

Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor 1 1Edited by I. Wilson

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
92
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(94 citation statements)
references
References 30 publications
2
92
0
Order By: Relevance
“…However, even by using a molecular model describing the potential binding mode of 1 within the hMMP-12 active site, it would be hard to predict the results reported in this study. The main reason for this is the fact that Lys 241 is located on a loop segment of hMMP-12, which, based on both x-ray and NMR studies of free hMMP-12 or in complex with synthetic inhibitors, displays high flexibility with the lysine side chain exhibiting high mobility (33)(34)(35). Superimposition of two hMMP-12 structure models, taken from an ensemble of twenty NMR-derived free hMMP-12 structures (34), provides some clues about the conformational space sampled by the Lys 241 side chain (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…However, even by using a molecular model describing the potential binding mode of 1 within the hMMP-12 active site, it would be hard to predict the results reported in this study. The main reason for this is the fact that Lys 241 is located on a loop segment of hMMP-12, which, based on both x-ray and NMR studies of free hMMP-12 or in complex with synthetic inhibitors, displays high flexibility with the lysine side chain exhibiting high mobility (33)(34)(35). Superimposition of two hMMP-12 structure models, taken from an ensemble of twenty NMR-derived free hMMP-12 structures (34), provides some clues about the conformational space sampled by the Lys 241 side chain (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…This mutation enables NMR studies of MMP-12 without turnover of substrate, without inhibitor, and without autolysis (36,58). The lack of structural perturbation by the mutation beyond the side chain itself is evident from comparison of crystal structures (9,30) and from the minimal and localized chemical shift perturbations of NMR spectra (36). Recombinant E219A-inactivated catalytic domain was prepared as described previously (36,58,59 NMR Spectroscopy-NMR spectra and titrations were acquired at 26°C on a Varian Inova 600-MHz spectrometer equipped with a high sensitivity 5-mm cryogenic HCN triple resonance probe with an actively shielded z-gradient coil.…”
Section: Methodsmentioning
confidence: 99%
“…MMI270 is a hydroxamate inhibitor that inhibits MMP-2, -3, -9, -14, and -12 at nanomolar concentrations. 37,38 This compound binds the S1Ј pocket of MMP enzymes, 39 affording it broader substrate specificity than BAY-129566. This activity underlies the clinical application of the compound, which is primarily aimed at lung fibrosis where macrophage-derived MMP-12 has been shown to underlie fibrogenesis.…”
Section: Mmp-12 Expression Is Markedly Induced In Glomeruli From Alpomentioning
confidence: 99%